Fresenius Medical Care AG & Co. KGaA Investor News Investor Relations Else-Kr ner-Str. 1 61352 Bad Homburg Germany Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: ir@fmc-ag.com North Ameri

Medical Care announces the offering of US$500 million and 300 million senior notes for refinancing and acquisition purposes

Bad Homburg, Germany - Fresenius

Medical Care AG & Co. KGaA ("the company" or "Fresenius Medical Care"), the world's largest

provider of dialysis products and services, today announced its intention to sell US$500 million of senior unsecured

notes due 2021 issued by Fresenius Medical Care US Finance, Inc. and 300 million of senior unsecured notes due 2021

issued by FMC Finance VII S.A. (together with the US$ senior notes "the senior notes"). Both issuers are wholly

owned subsidiaries of the company.

The senior notes will be guaranteed on a senior

basis jointly and severally by the company, Fresenius Medical Care Holdings, Inc. and Fresenius Medical Care Deutschland GmbH.

The senior notes will be offered through a

private placement directed to institutional investors. There will be no public offering of the senior notes. Proceeds from the offering will be used to repay indebtedness, for acquisitions including the company's

recently announced acquisition of Euromedic's dialysis service business and for general corporate purposes to support the

renal products and services business.

Fresenius Medical Care AG & Co. KGaA, January 21, 2011

The proposed offering will not be

registered under the Securities Act of 1933. The senior notes will be offered in the United States to "qualified

institutional buyers" pursuant to the exemption from registration under Rule 144A of the Securities Act and the

offering will be made in an "offshore transaction" pursuant to Regulation S under the Securities Act.

About Fresenius Medical Care

Fresenius Medical Care is the world's largest

integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition

that affects more than 1.89 million individuals worldwide. Through its network of 2,716 dialysis clinics in North America, Europe,

Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to 210,191 patients around the globe.

Fresenius Medical Care also is the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related

disposable products. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME, FME3) and the New York Stock Exchange

This release contains forward-looking statements

that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking

statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign

exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These

and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities

and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking

statements in this release.

This release does not constitute or form part

of, and should not be construed as, an offer or invitation to subscribe for, underwrite or otherwise acquire, any securities of

FMC Finance VII S.A., or Fresenius Medical Care US Finance, Inc. or Fresenius Medical Care or any present or future member of its

group nor should it or any part of it form the basis of, or be relied on in connection with, any contract to purchase or subscribe

for any securities of FMC Finance VII S.A. or Fresenius Medical Care US Finance, Inc. or Fresenius Medical Care or any member of

its group. In particular, this release is not an offer of securities in the United States of America (including its territories

and possessions), and securities of FMC Finance VII S.A. and Fresenius Medical Care US Finance, Inc. and Fresenius Medical Care

may not be offered or sold in the United States of America absent registration under the Securities Act of 1933, as amended, (which

FMC Finance VII S.A. and Fresenius Medical Care US Finance, Inc. and Fresenius Medical Care do not intend to effect) or pursuant

to an applicable exemption from registration.

Fresenius Medical Care AG & Co.

KGaA, January 21, 2011